Chris Fox
@ProfChrisPFox
Followers
1K
Following
1K
Statuses
644
Professor of Haematology & lymphoma-ologist, University of Nottingham. Chair, UK high-grade lymphoma study group. (no med advice)
United Kingdom
Joined July 2019
RT @act4patients: On this World Blood Cancer Day, we honour the unique journeys of individuals affected by blood cancers and proudly collab…
0
4
0
RT @Mc73James: Great start to the week. V positive meet with @SalimShafeek5 and Worcester Haem Team, followed up by really good TAP update…
0
1
0
Thank you @CureLeukaemia @Mc73James for your relentless focus & commitment on improving survival for patients with blood cancer via innovative clinical trials @charliecraddock @drpramilak #ProfSteveKnapper #TAPnetwork
@act4patients @PaulSherringto7 @HolesKC @manicmum35
Happy New Year from the Cure Leukaemia Team! This year brought significant advancements in blood cancer treatment, and we look forward to seeing even greater progress in 2025 for both adults and children worldwide 🌍🩸
2
2
7
Erudite review courtesy @AndyD1036
#Hematology The high-grade B-cell #lymphoma: double hit and more @BloodJournal @ASH_hematology #lymsm
0
0
3
Fantastic evening @StPaulsLondon hosted by @bloodcancer_uk @BloodCancer_Res c2000 people. Amazing carol concert & speakers. @campbellclaret #siennamiller #timothyspall et al @rowntron @rubina1402 @AdeleKFielding @MyMKaiser
1
4
41
RT @CureLeukaemia: "Having the funding from Cure Leukaemia is like a life line for us". Dr. Salim Shafeek from @WorcsAcuteNHS emphasises th…
0
4
0
Dr David Lewis 🇬🇧 presenting primary outcome data from the ENRICH RCT. Huge effort & important data @tobyeyre82 @MarkBishton @rule_simon
1
5
26
RT @JohnPLeonardMD: Here is #LeonardList #ASH24 top #lymphoma abstracts daily countdown – Number 3 – 235 Lewis – Ibrutinib-R superior to ch…
0
8
0
RT @act4patients: The ACT team are on their way to #ASH24 in San Diego this week! Read our blog for a preview of our goals for the event, a…
0
1
0
@alex_epi_tria @dgermain21 @chanyooncheah @majorajay @TheLancet @AnnaSureda5 @AstridPavlovsky @DrGarethGregor1 @mhertzberg10 Considered too ‘risky’ to omit R from 1L therapy.. Glofit has a silenced Fc region so as well as targeting a different epitope, R may contribute some ADCC from innate effectors. Thus the Ph1 NP40126 (manuscript in prep) included R & informed SKYGLO
0
0
4
0
0
0
RT @chanyooncheah: the practice changing STARGLO phase 3 trial demonstrating OS superiority for glofitamab-GemOx over R-GemOx in r/r DLBCL…
0
40
0
RT @SFBarringtonKCL: Pr Catherine Thieblemont @LysaLymphoma @WomenInLymphoma @lymphoma_uk meeting - MTV & ENsites on PET and LDH used routi…
0
8
0
Amazing work… fascinating
Stem cell transplants are amazing. A patient's diseased blood is replaced by a relative or stranger's. But what does putting a blood system into a new body do to the cells? How many survive? Does it matter? Out in @Nature today, we asked some basic Qs 👇
0
0
1
RT @thelimbichaemUK: REGISTER: Join @CwynKate & @DrChrisPFox for an overview of recent advances & a Q&A discussion…
0
2
0
RT @GeorgeLineker: Great to be up in Manchester for the @CureLeukaemia launch of the Aticus Project, helping children beat leukaemia https:…
0
21
0